Compare · CNSY vs MDLN

CNSY vs MDLN

Side-by-side comparison of Cerenome Inc. (CNSY) and Medline Inc. (MDLN): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNSY and MDLN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • MDLN is the larger of the two at $51.51B, about 7416.6x CNSY ($6.9M).
  • MDLN has been more active in the news (17 items in the past 4 weeks vs 10 for CNSY).
  • MDLN has more recent analyst coverage (25 ratings vs 0 for CNSY).
MetricCNSYMDLN
Company
Cerenome Inc.
Medline Inc.
Price
-
-
Market cap
$6.9M
$51.51B
1M return
-
+10.48%
1Y return
-
-3.90%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2025
News (4w)
10
17
Recent ratings
0
25
CNSY

Cerenome Inc.

Cerenome (Nasdaq: CNSY) is a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted therapeutics, and artificial intelligence to improve outcomes for patients with central nervous system cancers. The Company's CNSide Diagnostics platform supports the detection, molecular characterization, and longitudinal monitoring of CNS cancers through cerebrospinal fluid-based testing. Its lead therapeutic platform, REYOBIQ (rhenium Re186 obisbemeda), is being evaluated in clinical trials for leptomeningeal metastases, recurrent glioblastoma, and pediatric brain cancers. The data & artificial intelligence platform is designed to integrate diagnostic, molecular, imaging, and clinical data into actionable insights that support precision oncology and therapeutic innovation.

Latest CNSY

Latest MDLN